The PRESBYLENS™ Corneal Inlay (CI) is a unique, patented refractive surgery solution that is designed to correct vision lost by the natural aging process called presbyopia.
The PRESBYLENS™ CI, made from our proprietary microporous hydrogel material, is designed to be removable, adjustable and improve near vision with little or no compromise at distance.
The potential result is a significantly less risky and better-suited treatment of presbyopia than subtractive technologies such as LASIK.
ReVision Optics™, Inc., is a privately held corporation headquartered in Southern California.
|04/01/07||Series D||25M||Domain Associates, Canaan Partners, InterWest Partners||Unknown|